Thomas Bourgeron
Professor
University Paris Diderot
From this contributor
Expliquer la résilience à l’autisme peut faire naître de nouvelles thérapies
Explaining ‘resilience’ in autism may seed new therapies
Some individuals who have autism mutations show no signs of the condition; understanding why may lead to treatments.
Explaining ‘resilience’ in autism may seed new therapies
Questions for Thomas Bourgeron: In search of ‘second hits’
Taking a close look at people who have a mutation in a known autism gene may reveal why these people often have vastly different characteristics.
Questions for Thomas Bourgeron: In search of ‘second hits’
Explore more from The Transmitter
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.